By expenditures
| Name | Title | Type |
|---|---|---|
| Bryan Grunewald | Principal | Auditee |
| Danielle Gross | Controller | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 374413 | 2025 | 2025-12-12 | CLIFTONLARSONALLEN LLP | $3.59M |
| 332700 | 2024 | 2024-12-16 | Cliftonlarsonallen LLP | $3.33M |
| 8271 | 2023 | 2023-12-22 | Cliftonlarsonallen LLP | $5.93M |
| 21088 | 2022 | 2023-01-02 | Cliftonlarsonallen LLP | $5.93M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 332700 | 2024 | 2024-12-16 | 1090850 | 2024-002 | Significant Deficiency | - | I |
| 332700 | 2024 | 2024-12-16 | 1090849 | 2024-002 | Significant Deficiency | - | I |
| 332700 | 2024 | 2024-12-16 | 1090848 | 2024-002 | Significant Deficiency | - | I |
| 332700 | 2024 | 2024-12-16 | 1090847 | 2024-002 | Significant Deficiency | - | I |
| 332700 | 2024 | 2024-12-16 | 514408 | 2024-002 | Significant Deficiency | - | I |
| 332700 | 2024 | 2024-12-16 | 514407 | 2024-002 | Significant Deficiency | - | I |
| 332700 | 2024 | 2024-12-16 | 514406 | 2024-002 | Significant Deficiency | - | I |
| 332700 | 2024 | 2024-12-16 | 514405 | 2024-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 593059 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 593058 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 593057 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 593056 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 593055 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 16617 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 16616 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 16615 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 16614 | 2022-002 | Significant Deficiency | - | I |
| 21088 | 2022 | 2023-01-02 | 16613 | 2022-002 | Significant Deficiency | - | I |